Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation:a nationwide study

Laila Stærk; Emil Loldrup Fosbøl; Anders Nissen Bonde; Professor Gregory Lip; Christian Torp‐Pedersen; Gunnar Gislason

Related publications

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2016

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study

Laila Stærk, Emil Loldrup Fosbøl, Professor Gregory Lip, Morten Lamberts, Anders Nissen Bonde, Christian Torp‐Pedersen, Brice Ozenne, Thomas Alexander Gerds, Gunnar Gislason, Jonas Bjerring Olesen

Article2023

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study

Shin-Huei Liu, Yi‐Hsin Chan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih-Ann Chen

Article2016

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Torben Bjerregaard Larsen, Flemming Skjøth, Peter Brønnum Nielsen, Jette Nordstrøm Kjældgaard, Professor Gregory Lip

Article2021

Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants versus warfarin

Steven Deitelzweig, Allison Keshishian, A Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Professor Gregory Lip